LSNE Contract Manufacturing

About LSNE Contract Manufacturing

LSNE Contract Manufacturing (LSNE) is a trusted contract development and manufacturing organization (CDMO) serving the pharmaceutical, biotechnology and medical device industries for over 20 years. With six cGMP facilities across North America and Europe, LSNE specializes in process development, lyophilization cycle development, aseptic fill finish and lyophilization for a variety of delivery syst...

  • US
  • 2015
    On CPHI since
  • 250 - 499
    Employees
Company types
Contract Service
Manufacturer/Innovator
Contact info

Products from LSNE Contract Manufacturing (3)

  • Aseptic Fill Finish and Lyophilization Services

    Product Aseptic Fill Finish and Lyophilization Services

    LSNE has a long track record of success in pre-clinical, clinical and commercial aseptic fill finish, with hundreds of aseptic batches produced over two decades.  With seven aseptic automated fill lines to meet your capacity demands, we have the flexibility to sterile fill a range of dosage forms ...
  • Formulation and Lyophilization Cycle Development

    Product Formulation and Lyophilization Cycle Development

    LSNE is uniquely equipped to develop your formulation or lyophilization cycle from scratch or optimize your existing cycle to provide you with a commercially desirable process. LSNE utilizes Quality-by-Design (QbD) to perform multiple experiments in parallel, or accelerate one project in your program by ...
  • Medical Device Manufacturing

    Product Medical Device Manufacturing

    By partnering with more than fifty medical device clients, LSNE has developed the knowledge and the capacity to offer a flexible approach to medical device manufacturing.  With two licensed cGMP facilities that support medical device manufacturing, we’re built from the ground up to provide low cos...

LSNE Contract Manufacturing Resources (2)

  • News LSNE Receives Approval from AEMPS to Manufacture Biotechnology-based Therapeutic Products

    LSNE expands capabilities for aseptic fill finish of high-value biologics in Europe. This important approval builds upon LSNE’s well-established capabilities in providing aseptic fill finish of biologic products for clients at its US facilities.  These products include monoclonal antibodies, fusion proteins, replacement enzymes, plasmids, capsids, and oligonucleotides.
  • Brochure The Recognized Leader in Lyophilization & Sterile Manufacturing

    Over 20 Years of Delivering on Our Promises

    Choosing a reliable partner is critical to the success of the product you are developing. As the recognized leader in lyophilization and sterile manufacturing, your valuable API is in the hands of experts. We oversee the development and production of your drug product every step of the way. 


    Thousands of projects. Hundreds of successful client partnerships.